In the News Archives - Page 4 of 4 - Aria Pharmaceuticals

AI Player twoXAR Teams Up with 1ST Biotherapeutics on Glioblastoma

twoXAR and South Korea’s 1ST Biotherapeutics are joining forces to discover and develop new treatments for glioblastoma, the most aggressive kind of brain cancer. Under the deal, twoXAR will identify drug candidates using its artificial intelligence platform, both partners will select promising candidates and 1ST Bio will develop them.

A Startup that Uses Software to Discover New Drugs Just Raised $10 Million

twoXAR, a startup that uses software to discover new experimental drugs, just raised $10 million USD. The Series A round was led by SoftBank.

Bioinformatics startup twoXAR bags $10M in Series A

JP Lee, managing director of SoftBank Ventures, will join Andreessen Horowitz general partner Vijay Pande on the twoXAR board of directors. Palo Alto, California-based twoXAR reached this next stage of growth thanks to $3.4 million in seed funding it picked up in 2014 in part from Andreessen Horowitz.

twoXAR Lands $10M to Ramp Up AI-Based Drug Discovery Work

Palo Alto, CA-based twoXAR has developed a drug discovery computing platform that it says is faster, less expensive, and more accurate than traditional laboratory approaches. The company claims it can identify drug candidates for testing “in weeks rather than years.” The company adds that the technology has yielded potential drugs in a wide range of diseases including liver cancer, rheumatoid arthritis, and type 2 diabetes.

AI-powered Drug Discovery Captures Pharma Interest

Andreessen Horowitz Adds General Partner for Bio Fund

Venture firm Andreessen Horowitz said Jorge Conde has joined the firm as a general partner.

The Hopeful Future of Precision Medicine

Many of us have experienced the pitfalls of a “one-size-fits” all approach to medicine, where physicians prescribe treatment for the “average patient” instead of the one sitting in front of them. By not accounting for the variability in genes, environment, and lifestyle that are often so closely tied to health and illness, treatments end up falling short and sometimes do more harm than good. Fortunately, the “precision medicine” movement, which takes into account the patient’s unique characteristics when prescribing treatment and prevention strategies, has gained traction in recent years.

News and Events Category: In the News